RecruitingNot Applicable

Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.

Czechia, Germany7,000 participantsStarted 2024-03-01

Plain-language summary

The RECLAIM study aims to gather a centralized and harmonized dataset, enabling the secondary use of data for building AI-based models that will support diagnosis and prognosis of individual Multiple Sclerosis patient's disease course and treatment response in a real-world setting. Additionally, the data will be used to generate further insights on Multiple Sclerosis progression as well as to develop the tools to monitor this progression.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: * Patients must have a confirmed diagnosis of MS, NMOSD, MOGAD, CIS or RIS. * Patient (or patient's legal representative) has previously signed and dated an informed consent form (ICF) for the secondary use of their data, or assent form. Alternatively, the secondary use of the patient's data is allowed following Institutional Review Board (IRB)/Ethical Committee (EC) approval in accordance with national and local subject privacy regulations. Exclusion criteria: * Patients under 18 years of age will be excluded. * Other unspecified reasons that, in the opinion of the Investigator or Joint Steering Committee, make the patient unsuitable for participation in the study.

What they're measuring

The number of patients from each institution who have contributed data to the database.

Timeframe: 4 years

The number of patients from each institution whose data was mapped to the common data model of the harmonised database.

Timeframe: 4 years

The number of patients from the control arms of clinical trials who have contributed data to the database.

Timeframe: 4 years

The data completeness of each variable in the harmonised database.

Timeframe: 4 years

Trial details

NCT IDNCT06280755

Sponsoricometrix

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2027-04

Contact for this trial

Diana M Sima, PhD

+32 16 369 000 diana.sima@icometrix.com

View on ClinicalTrials.gov More Multiple Sclerosis trials

Plain-language summary

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

The number of patients from each institution who have contributed data to the database.

Timeframe: 4 years

The number of patients from each institution whose data was mapped to the common data model of the harmonised database.

Timeframe: 4 years

The number of patients from the control arms of clinical trials who have contributed data to the database.

Timeframe: 4 years

The data completeness of each variable in the harmonised database.

Timeframe: 4 years